In AITL, TET2 and DNMT3A mutations can be detected not only in neoplastic T cells, but also in B cells36 and CD34+ stem and progenitor cells67, suggesting that these events occur at an early stage during AITL lymphomagenesis (Fig. 3). This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.